Dupont Capital Management Corp reduced its stake in MAXIMUS, Inc. (NYSE:MMS) by 5.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,083 shares of the health services provider’s stock after selling 1,763 shares during the quarter. Dupont Capital Management Corp’s holdings in MAXIMUS were worth $1,827,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently modified their holdings of MMS. Bruderman Asset Management LLC purchased a new stake in MAXIMUS during the 2nd quarter valued at $119,000. Fort L.P. purchased a new stake in MAXIMUS during the 2nd quarter valued at $120,000. Violich Capital Management Inc. purchased a new stake in MAXIMUS during the 2nd quarter valued at $204,000. Tower Research Capital LLC TRC raised its stake in MAXIMUS by 72.4% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,061 shares of the health services provider’s stock valued at $253,000 after buying an additional 1,706 shares during the last quarter. Finally, Engineers Gate Manager LP purchased a new stake in MAXIMUS during the 3rd quarter valued at $254,000. 93.29% of the stock is currently owned by hedge funds and other institutional investors.

MMS has been the subject of several analyst reports. Zacks Investment Research upgraded MAXIMUS from a “sell” rating to a “hold” rating in a research note on Tuesday, August 14th. Canaccord Genuity upped their price objective on MAXIMUS from $64.00 to $67.00 and gave the stock a “hold” rating in a research note on Wednesday, October 10th. Finally, ValuEngine upgraded MAXIMUS from a “hold” rating to a “buy” rating in a research note on Friday, November 30th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. MAXIMUS has an average rating of “Buy” and an average target price of $72.00.

Shares of NYSE:MMS traded down $0.52 during midday trading on Friday, hitting $69.86. The company had a trading volume of 660,408 shares, compared to its average volume of 432,378. The firm has a market capitalization of $4.51 billion, a price-to-earnings ratio of 20.55, a price-to-earnings-growth ratio of 1.92 and a beta of 1.03. MAXIMUS, Inc. has a 12-month low of $60.00 and a 12-month high of $72.71.

MAXIMUS (NYSE:MMS) last posted its quarterly earnings data on Tuesday, November 20th. The health services provider reported $0.71 EPS for the quarter, missing the consensus estimate of $0.72 by ($0.01). The company had revenue of $558.50 million during the quarter, compared to analysts’ expectations of $587.58 million. MAXIMUS had a return on equity of 20.23% and a net margin of 9.23%. The company’s revenue for the quarter was down 10.0% on a year-over-year basis. During the same quarter last year, the company earned $0.81 earnings per share. Research analysts anticipate that MAXIMUS, Inc. will post 3.66 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Friday, November 30th. Investors of record on Thursday, November 15th were issued a $0.25 dividend. The ex-dividend date was Wednesday, November 14th. This represents a $1.00 annualized dividend and a yield of 1.43%. This is an increase from MAXIMUS’s previous quarterly dividend of $0.05. MAXIMUS’s dividend payout ratio is currently 29.41%.

In related news, General Counsel David Francis sold 6,220 shares of the company’s stock in a transaction on Monday, October 1st. The shares were sold at an average price of $63.86, for a total value of $397,209.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Russell A. Beliveau sold 1,000 shares of the company’s stock in a transaction on Monday, October 1st. The stock was sold at an average price of $63.86, for a total transaction of $63,860.00. The disclosure for this sale can be found here. Insiders sold a total of 133,124 shares of company stock valued at $9,005,450 in the last ninety days. 3.10% of the stock is currently owned by insiders.

TRADEMARK VIOLATION WARNING: This story was first posted by Marea Informative and is the sole property of of Marea Informative. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.mareainformativa.com/news/2018/12/08/dupont-capital-management-corp-lowers-stake-in-maximus-inc-mms-updated-updated-updated.html.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews.

Recommended Story: What is systematic risk?

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.